C Ayers - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C Ayers

Showing results (181-190 of 183) with videos related to

Pageof 19

Sort By:

You have reached the last page of results.This site can display upto 183 results.

Cancer|October 1, 2019

Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failureEmily C Ayers, Shaoying Li, L Jeffrey Medeiros, et al.

Blood|July 15, 2025

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamabTaylor R Brooks, Emily C Zabor, Yohanna Bedelu, et al.

Blood|September 27, 2021

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutionsVictor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, et al.

Pageof 19

Search research articles

Showing results (181-190 of 183) with videos related to

Sort By:

Pageof 19

You have reached the last page of results.This site can display upto 183 results.

Cancer|October 1, 2019

Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failureEmily C Ayers, Shaoying Li, L Jeffrey Medeiros, et al.

Blood|July 15, 2025

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamabTaylor R Brooks, Emily C Zabor, Yohanna Bedelu, et al.

Blood|September 27, 2021

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutionsVictor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, et al.

Pageof 19